Email this article 
Analysis of the State Pharmacopoiea’s of the Russian Federation requirements’ coverage of drug products and drug substance of different origin and drug products included in the list of vital and primary drug products
- Authors: Yarutkin A.V.1, Bagirova V.L.1, Berezhnaya E.S.2
- Affiliations:
- Scientific Center for the Examination of Medical Products, Moscow, Russia
- Rostov State Medical University, Rostov-on-Don, Russia
- Issue: No 2 (2023)
- Pages: 133-136
- Section: Articles
- URL: https://remedium-journal.ru/journal/article/view/1627
- DOI: https://doi.org/10.32687/1561-5936-2023-27-2-133-136
- Cite item
Abstract
This article provides an overview of structure of monographs of The State Pharmacopoeia of the Russian Federation (XIV edition) according to origin of drug products and drug substances. Present article also provides data on comparative analysis of enacted monographs with The List of vital and primary drug products considering the dosage forms.
About the authors
Alexey V. Yarutkin
Scientific Center for the Examination of Medical Products, Moscow, Russia
Email: 001
Valeria L. Bagirova
Scientific Center for the Examination of Medical Products, Moscow, Russia
Email: 002
Elizaveta S. Berezhnaya
Rostov State Medical University, Rostov-on-Don, Russia
Email: 003
References
- Frolova L. N., Kovaleva E. L., Sakanyan E. I. et al. Comparative analysis of the nomenclature of medicinal plant raw materials used in domestic and world pharmacopoeia practice. Scientific Centre for Expert Evaluation of Medicinal Products bulletin. 2020;10(1):29—40. doi: 10.30895/1991-2919-2020-10-1-29-40
- Akamova A. V., Nemyatykh O. D., Narkevich I. A. Multi-vector marketing analysis of the Russian market of phytopreparations. Development and Registration of Medicines. 2017;(4):276—280.
- Dubrovina O. N. Strategy, tactics, practice in the medicinal providing a stationary segment. Ugra Healthcare: Experience and Innovations. 2022;(1):3—9.
